These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 32653650)

  • 41. Use of herbal drugs to treat COVID-19 should be with caution.
    Yang Y
    Lancet; 2020 May; 395(10238):1689-1690. PubMed ID: 32422123
    [No Abstract]   [Full Text] [Related]  

  • 42. May drug-related cardiovascular toxicities persist after hospital discharge in COVID-19 patients?
    Kara E; Inkaya AC; Demirkan K
    Int J Antimicrob Agents; 2020 Jun; 55(6):106003. PubMed ID: 32360773
    [No Abstract]   [Full Text] [Related]  

  • 43. [Challenges for psychotropics in the context of the SARS-Cov-2 pandemic].
    Javelot H; Llorca PM; Meyer G; Fossati P; Haffen E
    Encephale; 2020 Jun; 46(3S):S116-S118. PubMed ID: 32360037
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Skin manifestations associated with the new coronavirus SARS-CoV-2 disease.
    Redondo-Sendino Á; González Sánchez IC; de Victoria Fernández B
    Med Clin (Barc); 2020 Nov; 155(9):414-415. PubMed ID: 32873395
    [No Abstract]   [Full Text] [Related]  

  • 45. COVID-19 & antiepileptic drugs: Should we pay attention?
    Fırat O; Yalçın N; Demirkan K
    Seizure; 2020 Aug; 80():240-241. PubMed ID: 32663783
    [No Abstract]   [Full Text] [Related]  

  • 46. Coronavirus disease 2019 (COVID-19): first indication of efficacy of Gene-Eden-VIR/Novirin in SARS-CoV-2 infection.
    Polansky H; Lori G
    Int J Antimicrob Agents; 2020 Jun; 55(6):105971. PubMed ID: 32283177
    [No Abstract]   [Full Text] [Related]  

  • 47. Discovering small-molecule therapeutics against SARS-CoV-2.
    Tiwari V; Beer JC; Sankaranarayanan NV; Swanson-Mungerson M; Desai UR
    Drug Discov Today; 2020 Aug; 25(8):1535-1544. PubMed ID: 32574699
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Approaches and advances in the development of potential therapeutic targets and antiviral agents for the management of SARS-CoV-2 infection.
    Krishna G; Pillai VS; Veettil MV
    Eur J Pharmacol; 2020 Oct; 885():173450. PubMed ID: 32739174
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Considerations for Statin Therapy in Patients with COVID-19.
    Dashti-Khavidaki S; Khalili H
    Pharmacotherapy; 2020 May; 40(5):484-486. PubMed ID: 32267560
    [No Abstract]   [Full Text] [Related]  

  • 50. Structural Biology Aids the Research of New Anti-COVID-19 Drugs.
    Lu J; Liu X
    Curr Org Synth; 2020; 17(3):162-163. PubMed ID: 32538717
    [No Abstract]   [Full Text] [Related]  

  • 51. An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics.
    Wang D; Li Z; Liu Y
    J Infect Public Health; 2020 Oct; 13(10):1405-1414. PubMed ID: 32684351
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Arbidol: A potential antiviral drug for the treatment of SARS-CoV-2 by blocking trimerization of the spike glycoprotein.
    Vankadari N
    Int J Antimicrob Agents; 2020 Aug; 56(2):105998. PubMed ID: 32360231
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A fatal case of COVID-19 pneumonia occurring in a patient with severe acute ulcerative colitis.
    Mazza S; Sorce A; Peyvandi F; Vecchi M; Caprioli F
    Gut; 2020 Jun; 69(6):1148-1149. PubMed ID: 32245909
    [No Abstract]   [Full Text] [Related]  

  • 54. Sofosbuvir as a potential option for the treatment of COVID-19.
    Nourian A; Khalili H
    Acta Biomed; 2020 May; 91(2):236-238. PubMed ID: 32420958
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment and Outcome of a Patient With Lung Cancer Infected With Severe Acute Respiratory Syndrome Coronavirus-2.
    Zhang H; Xie C; Huang Y
    J Thorac Oncol; 2020 May; 15(5):e63-e64. PubMed ID: 32147577
    [No Abstract]   [Full Text] [Related]  

  • 56. Statins in coronavirus outbreak: It's time for experimental and clinical studies.
    Bifulco M; Gazzerro P
    Pharmacol Res; 2020 Jun; 156():104803. PubMed ID: 32289478
    [No Abstract]   [Full Text] [Related]  

  • 57. The Possible Protective Role of α-Synuclein Against Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Patients With Parkinson's Disease.
    Ait Wahmane S; Achbani A; Ouhaz Z; Elatiqi M; Belmouden A; Nejmeddine M
    Mov Disord; 2020 Aug; 35(8):1293-1294. PubMed ID: 32519352
    [No Abstract]   [Full Text] [Related]  

  • 58. Anaphylactic shock following the diagnosis of coronavirus disease 2019.
    Alvarez-Perea A; Baeza ML
    Ann Allergy Asthma Immunol; 2020 Oct; 125(4):477-478. PubMed ID: 32745608
    [No Abstract]   [Full Text] [Related]  

  • 59. Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients.
    Su HX; Yao S; Zhao WF; Li MJ; Liu J; Shang WJ; Xie H; Ke CQ; Hu HC; Gao MN; Yu KQ; Liu H; Shen JS; Tang W; Zhang LK; Xiao GF; Ni L; Wang DW; Zuo JP; Jiang HL; Bai F; Wu Y; Ye Y; Xu YC
    Acta Pharmacol Sin; 2020 Sep; 41(9):1167-1177. PubMed ID: 32737471
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is the type of diabetes treatment relevant to outcome of COVID-19?
    Bloomgarden Z
    J Diabetes; 2020 Jul; 12(7):486-487. PubMed ID: 32353193
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.